Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Gross Profit (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Gross Profit for 17 consecutive years, with $8.4 billion as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 11.62% to $8.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.3 billion through Dec 2025, changed 0.22% year-over-year, with the annual reading at $34.3 billion for FY2025, 0.22% changed from the prior year.
  • Gross Profit for Q4 2025 was $8.4 billion at Bristol Myers Squibb, down from $8.8 billion in the prior quarter.
  • The five-year high for Gross Profit was $9.6 billion in Q4 2021, with the low at $7.5 billion in Q4 2024.
  • Average Gross Profit over 5 years is $8.8 billion, with a median of $8.8 billion recorded in 2022.
  • The sharpest move saw Gross Profit rose 24.51% in 2021, then dropped 13.77% in 2024.
  • Over 5 years, Gross Profit stood at $9.6 billion in 2021, then fell by 8.47% to $8.8 billion in 2022, then dropped by 0.92% to $8.7 billion in 2023, then decreased by 13.77% to $7.5 billion in 2024, then increased by 11.62% to $8.4 billion in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $8.4 billion, $8.8 billion, and $8.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.